Skip to main content

Main menu

  • Home
  • Current issue
  • Early View
  • Archive
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Institutional open access agreements
    • Peer reviewer login
  • Alerts
  • Subscriptions
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

User menu

  • Log in
  • Subscribe
  • Contact Us
  • My Cart

Search

  • Advanced search
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

Login

European Respiratory Society

Advanced Search

  • Home
  • Current issue
  • Early View
  • Archive
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Institutional open access agreements
    • Peer reviewer login
  • Alerts
  • Subscriptions

Interstitial and orphan lung disease

  • Protocol for long-term effect of pulmonary rehabilitation under nintedanib in idiopathic pulmonary fibrosis
    Osamu Nishiyama, Kensuke Kataoka, Masahiko Ando, Shinichi Arizono, Akira Morino, Koichi Nishimura, Tomoya Ogawa, Akira Shiraki, Fumiko Watanabe, Ryo Kozu, Takashi Ogura, Yasuhiro Kondoh
    ERJ Open Research Jul 2021, 7 (3) 00321-2021; DOI: 10.1183/23120541.00321-2021
  • Awake or intubated surgery in diagnosis of interstitial lung diseases? A prospective study
    Francesco Guerrera, Lorena Costardi, Giulio L. Rosboch, Paraskevas Lyberis, Edoardo Ceraolo, Paolo Solidoro, Claudia Filippini, Giulia Verri, Luca Brazzi, Carlo Albera, Enrico Ruffini
    ERJ Open Research Jul 2021, 7 (3) 00630-2020; DOI: 10.1183/23120541.00630-2020
  • Body mass index and in-hospital mortality in patients with acute exacerbation of idiopathic pulmonary fibrosis
    Nobuyasu Awano, Taisuke Jo, Hideo Yasunaga, Minoru Inomata, Naoyuki Kuse, Mari Tone, Kojiro Morita, Hiroki Matsui, Kiyohide Fushimi, Takahide Nagase, Takehiro Izumo
    ERJ Open Research Apr 2021, 7 (2) 00037-2021; DOI: 10.1183/23120541.00037-2021
  • Endobronchial autologous bone marrow–mesenchymal stromal cells in idiopathic pulmonary fibrosis: a phase I trial
    Arantza Campo, José María González-Ruiz, Enrique Andreu, Ana B. Alcaide, María M. Ocón, Juan De-Torres, Jesús Pueyo, Rosa Cordovilla, Eva Villaron, Fermín Sanchez-Guijo, Miguel Barrueco, Jorge Nuñez-Córdoba, Felipe Prósper, Javier J. Zulueta
    ERJ Open Research Apr 2021, 7 (2) 00773-2020; DOI: 10.1183/23120541.00773-2020
  • Study design of a randomised, placebo-controlled trial of nintedanib in children and adolescents with fibrosing interstitial lung disease
    Robin Deterding, Matthias Griese, Gail Deutsch, David Warburton, Emily M. DeBoer, Steven Cunningham, Annick Clement, Nicolaus Schwerk, Kevin R. Flaherty, Kevin K. Brown, Florian Voss, Ulrike Schmid, Rozsa Schlenker-Herceg, Daniela Verri, Mihaela Dumistracel, Marilisa Schiwek, Susanne Stowasser, Kay Tetzlaff, Emmanuelle Clerisme-Beaty, Lisa R. Young
    ERJ Open Research Apr 2021, 7 (2) 00805-2020; DOI: 10.1183/23120541.00805-2020
  • Transition of patients with interstitial lung disease from paediatric to adult care
    Václav Koucký, Petr Pohunek, Martina Vašáková, Andrew Bush
    ERJ Open Research Apr 2021, 7 (2) 00964-2020; DOI: 10.1183/23120541.00964-2020
  • Spectrum of childhood interstitial and diffuse lung diseases at a tertiary hospital in Egypt
    Salma G. Abdelhady, Eman M. Fouda, Malak A. Shaheen, Faten A. Ghazal, Ahmed M. Mostafa, Ahmed M. Osman, Andrew G. Nicholson, Heba M. Hamza
    ERJ Open Research Apr 2021, 7 (2) 00880-2020; DOI: 10.1183/23120541.00880-2020
  • Design and rationale of a randomised, double-blind trial of the efficacy and safety of pirfenidone in patients with fibrotic hypersensitivity pneumonitis
    Evans R. Fernández Pérez, James L. Crooks, Jeffrey J. Swigris, Joshua J. Solomon, Michael P. Mohning, Tristan J. Huie, Matthew Koslow, David A. Lynch, Steve D. Groshong, Kaitlin Fier
    ERJ Open Research Apr 2021, 7 (2) 00054-2021; DOI: 10.1183/23120541.00054-2021
  • Anti-HSP47 siRNA lipid nanoparticle ND-L02-s0201 reverses interstitial pulmonary fibrosis in preclinical rat models
    Yun Liu, Jian Liu, Alistair Quimbo, Fengcheng Xia, Jiping Yao, Jean-Pierre Clamme, Sonya Zabludoff, Jun Zhang, Wenbin Ying
    ERJ Open Research Apr 2021, 7 (2) 00733-2020; DOI: 10.1183/23120541.00733-2020
  • Telomere shortening and DNA damage in culprit cells of different types of progressive fibrosing interstitial lung disease
    Aernoud A. van Batenburg, Karin M. Kazemier, Matthijs F.M. van Oosterhout, Joanne J. van der Vis, Jan C. Grutters, Roel Goldschmeding, Coline H.M. van Moorsel
    ERJ Open Research Apr 2021, 7 (2) 00691-2020; DOI: 10.1183/23120541.00691-2020

Pages

  • Previous
  • Next
  • 1
  • …
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • …
  • 19
  • Acute lung injury and critical care (48)
  • Asthma and allergy (252)
  • CF and non-CF bronchiectasis (147)
  • COPD and smoking (361)
  • Epidemiology, occupational and environmental lung disease (63)
  • Genetics (30)
  • Interstitial and orphan lung disease (191)
  • Lung biology and experimental studies (92)
  • Lung cancer (82)
  • Lung imaging (63)
  • Lung structure and function (120)
  • Mechanisms of lung disease (5)
  • Paediatric pulmonology (116)
  • Pulmonary pharmacology and therapeutics (146)
  • Pulmonary vascular disease (97)
  • Respiratory clinical practice (98)
  • Respiratory infections and tuberculosis (380)
  • Sleep medicine (63)
  • Most Read
  • Twitter
Loading
  • Persistent symptoms 3 months after a SARS-CoV-2 infection: the post-COVID-19 syndrome?
  • IQOS exposure impairs human airway cell homeostasis: direct comparison with traditional cigarette and e-cigarette
  • Predicting and preventing hospital readmission for exacerbations of COPD
  • The safety of cardioselective β1-blockers in asthma: literature review and search of global pharmacovigilance safety reports
  • Prevalence, time trends and treatment practices of asthma in India: the Global Asthma Network study
More...

Navigate

  • Home
  • Current issue
  • Archive

About ERJ Open Research

  • Editorial board
  • Journal information
  • Press
  • Permissions and reprints
  • Advertising

The European Respiratory Society

  • Society home
  • myERS
  • Privacy policy
  • Accessibility

ERS publications

  • European Respiratory Journal
  • ERJ Open Research
  • European Respiratory Review
  • Breathe
  • ERS books online
  • ERS Bookshop

Help

  • Feedback

For authors

  • Instructions for authors
  • Publication ethics and malpractice
  • Submit a manuscript

For readers

  • Alerts
  • Subjects
  • RSS

Subscriptions

  • Accessing the ERS publications

Contact us

European Respiratory Society
442 Glossop Road
Sheffield S10 2PX
United Kingdom
Tel: +44 114 2672860
Email: journals@ersnet.org

ISSN

Online ISSN: 2312-0541

Copyright © 2023 by the European Respiratory Society